학술논문
P-132 - Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets
Document Type
Abstract
Author
Source
In Annals of Oncology June 2018 29 Supplement 5:v36-v36
Subject
Language
ISSN
0923-7534